ASBP

0.20

4.49% -0.0094

Pre-mercato: .20

Aspire Biopharma Holdings Inc (ASBP)

Panoramica Notizia Cronologia dei prezzi Forum Previsione

Precedente Chiudi:

$0.2094

Aprire:

$0.1987

Volume 24 ore:

2.85M

Relative Volume:

0.30

Capitalizzazione di mercato:

$1.00M

Reddito:

$6,200

Utile/perdita netta:

$-24.48M

Rapporto P/E:

-0.0412

EPS:

-4.8539

Flusso di cassa netto:

$-4.92M

1 W Prestazione:

-4.17%

1M Prestazione:

-80.39%

6M Prestazione:

-98.56%

1 anno Prestazione:

-98.63%

Intervallo 1D:

$0.196

$0.2037

Intervallo di 1 settimana:

$0.1954

$0.2498

Portata 52W:

$0.1643

$35.01

Aspire Biopharma Holdings Inc Stock (ASBP) Company Profile

Nome

Aspire Biopharma Holdings Inc

Settore

Healthcare (1106)

Industria

Biotechnology (615)

Telefono

561-704-8527

Indirizzo

23150 FASHION DRIVE, SUITE 232, ESTERO

Dipendente

Cinguettio

Prossima data di guadagno

2026-05-13

Ultimi documenti SEC

ASBP's Discussions on Twitter

Compare ASBP vs VRTX, REGN, ARGX, ALNY, ONC

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ASBP Aspire Biopharma Holdings Inc	0.20	1.00M	6,200	-24.48M	-4.92M	-4.8539
VRTX Vertex Pharmaceuticals Inc	424.36	107.87B	12.32B	4.34B	3.19B	16.86
REGN Regeneron Pharmaceuticals Inc	702.27	73.63B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	794.70	49.42B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	301.11	40.20B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	297.49	33.06B	5.36B	287.73M	924.18M	2.5229

Aspire Biopharma Holdings Inc Borsa (ASBP) Ultime notizie

May 02, 2026

ASBP Stock Jumps 21% On Buyback Offer – Retail Believes Every Dip’s A Buying Opportunity - MSN

May 02, 2026

May 01, 2026

Why Qualcomm Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - Sahm

May 01, 2026

ASBP Stock Price, Quote & Chart | ASPIRE BIOPHARMA HOLDINGS IN (NASDAQ:ASBP) - ChartMill

May 01, 2026

Apr 30, 2026

Aspire Biopharma's BUZZ BOMB(TM) Disrupts Energy Category with New Convenience Store Pack - Stevens Point Journal

Apr 30, 2026

ASBP: A Platform Approach to Drug Delivery with an Unconventional Path to Commercialization - Zacks Small Cap Research

Apr 30, 2026

Aspire Biopharma (ASBP) asks holders to approve warrants, $0.00001 exercise price - Stock Titan

Apr 28, 2026

Apr 27, 2026

Aspire Biopharma authorizes $5 million stock buyback program By Investing.com - Investing.com South Africa

Apr 27, 2026

Aspire Biopharma authorizes $5 million stock buyback program - Investing.com UK

Apr 27, 2026

Aspire Biopharma Announces $5.0 Million Share Repurchase Program - ACCESS Newswire

Apr 27, 2026

No expiration date: Aspire can spend up to $5M buying back shares - Stock Titan

Apr 27, 2026

Aspire Biopharma's Wholly Owned Subsidiary, Buzz Bomb Caffeine Company, Partners with Blue Shark Beverages to Expand Southern California Distribution - Bluffton Today

Apr 27, 2026

Apr 26, 2026

Aspire Biopharma secures up to $21M in convertible preferred stock financing - MSN

Apr 26, 2026

Aspire Biopharma's Wholly Owned Subsidiary, Buzz Bomb Caffeine Company, to Showcase BUZZ BOMB(TM) Caffeine and its Innovative Sublingual Delivery Technology at The Sports & Active Nutrition Summit - Bluffton Today

Apr 26, 2026

Aspire Biopharma names new executive chair - MSN

Apr 26, 2026

Apr 24, 2026

Aspire Biopharma Announces Closing of Second and Final Tranche of $21 Million Private Placement by Select Investors; Secures Commitment Letter for $22.5M Credit Facility to Fund the DCS Acquisition - Corsicana Daily Sun

Apr 24, 2026

ASBP Technical Analysis | Trend, Signals & Chart Patterns | ASPIRE BIOPHARMA HOLDINGS IN (NASDAQ:ASBP) - ChartMill

Apr 24, 2026

Apr 22, 2026

ASBPW (Aspire Bio) leadership prioritizes late-stage clinical trial advancement to drive long-term shareholder value.Verified Stock Signals - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 22, 2026

Aspire Bio (ASBP) Stock Employment Data (+8.28%) 2026-04-22Shared Trade Alerts - Xã Thanh Hà

Apr 22, 2026

Apr 21, 2026

ASBP Financials: Income Statement, Balance Sheet & Cash Flow | Aspire Biopharma Holdings Inc - Stock Titan

Apr 21, 2026

ASBP Stock Back On Retail Radar After 78% Crash – Bulls Eye $1 Comeback - Stocktwits

Apr 21, 2026

Why Amazon Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Sahm

Apr 21, 2026

LCID, ASBP, WLDS Stocks Hit 52-Week Lows: What Drove The Selloff? - Stocktwits

Apr 21, 2026

Aspire Biopharma Holdings Inc Azioni (ASBP) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

ROIV

$28.32

0.14%

RPRX

$50.44

0.48%

BNTX

$95.50

3.88%

INSM

$139.44

0.41%

RVMD

$147.21

0.47%

ONC

$297.49

0.12%

Aspire Biopharma Holdings Inc (ASBP)

Aspire Biopharma Holdings Inc Stock (ASBP) Company Profile

Compare ASBP vs VRTX, REGN, ARGX, ALNY, ONC

Aspire Biopharma Holdings Inc Borsa (ASBP) Ultime notizie

ASBP Stock Jumps 21% On Buyback Offer – Retail Believes Every Dip’s A Buying Opportunity - MSN

Why Qualcomm Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - Sahm

ASBP Stock Price, Quote & Chart | ASPIRE BIOPHARMA HOLDINGS IN (NASDAQ:ASBP) - ChartMill

Aspire Biopharma's BUZZ BOMB(TM) Disrupts Energy Category with New Convenience Store Pack - Stevens Point Journal

ASBP: A Platform Approach to Drug Delivery with an Unconventional Path to Commercialization - Zacks Small Cap Research

ASBP - Finviz

LCID, ASBP, WLDS stocks hit 52-week lows: What drove the selloff? - MSN

12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga

ASBP bulls back in control after 78% crash: What changed? - MSN

Aspire Biopharma announces $5M share repurchase program - MSN

Aspire Biopharma regains Nasdaq minimum bid price compliance - MSN

Aspire Biopharma (ASBP) asks holders to approve warrants, $0.00001 exercise price - Stock Titan

Aspire Biopharma authorizes $5 million stock buyback program By Investing.com - Investing.com South Africa

Aspire Biopharma authorizes $5 million stock buyback program - Investing.com UK

Aspire Biopharma Announces $5.0 Million Share Repurchase Program - ACCESS Newswire

No expiration date: Aspire can spend up to $5M buying back shares - Stock Titan

Aspire Biopharma's Wholly Owned Subsidiary, Buzz Bomb Caffeine Company, Partners with Blue Shark Beverages to Expand Southern California Distribution - Bluffton Today

Aspire Biopharma secures up to $21M in convertible preferred stock financing - MSN

Aspire Biopharma's Wholly Owned Subsidiary, Buzz Bomb Caffeine Company, to Showcase BUZZ BOMB(TM) Caffeine and its Innovative Sublingual Delivery Technology at The Sports & Active Nutrition Summit - Bluffton Today

Aspire Biopharma names new executive chair - MSN

Aspire Biopharma Announces Closing of Second and Final Tranche of $21 Million Private Placement by Select Investors; Secures Commitment Letter for $22.5M Credit Facility to Fund the DCS Acquisition - Corsicana Daily Sun

ASBP Technical Analysis | Trend, Signals & Chart Patterns | ASPIRE BIOPHARMA HOLDINGS IN (NASDAQ:ASBP) - ChartMill

ASBPW (Aspire Bio) leadership prioritizes late-stage clinical trial advancement to drive long-term shareholder value.Verified Stock Signals - Cổng thông tin điện tử tỉnh Tây Ninh

Aspire Bio (ASBP) Stock Employment Data (+8.28%) 2026-04-22Shared Trade Alerts - Xã Thanh Hà

ASBP Financials: Income Statement, Balance Sheet & Cash Flow | Aspire Biopharma Holdings Inc - Stock Titan

ASBP Stock Back On Retail Radar After 78% Crash – Bulls Eye $1 Comeback - Stocktwits

Why Amazon Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Sahm

LCID, ASBP, WLDS Stocks Hit 52-Week Lows: What Drove The Selloff? - Stocktwits

Aspire Biopharma Holdings Inc Azioni (ASBP) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a ASBP